Please join our staff as we participate or present in the following oral and poster presentations at the 2016 ASTRO Annual Meeting
Oral Presentations
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
7:45 a.m.
Co-Authors: Vargo JA, Ward MC, Caudell JJ, Riaz N, Dunlap NE, Isrow D, Zakem SJ, Dault J, Awan MJ, Higgins KA, Beitler JJ, Yao M, Machtay M, Siddiqui F, Trotti AM, Lee NY, Koyfman SA, Heron DE
Optimal Treatment Selection of SBRT and IMRT for Re-Irradiation of Head and Neck Cancer: A Multi-Institution Comparison
160 A/B/C
7:55 a.m.
Presenter: Matthew Ward, MD
Co-Authors: Riaz N, Caudell JJ, Dunlap NE, Isrow D, Zakem SJ, Dault J, Awan MJ, Vargo JA, Heron DE, Higgins KA, Beitler JJ, Yao M, Machtay M, Siddiqui F, Trotti AM, Lee NY, Koyfman SA
Multi-Institution Analysis of IMRT-based Re-Irradiation for Head and Neck Cancer: Prognostic Factors and Recursive Partitioning Analysis for Overall Survival
160 A/B/C
8:05 a.m.
Co-Authors: Caudell JJ, Ward MC, Koyfman S, Riaz N, Dunlap NE, Isrow D, Zakem SJ, Awan MJ, Vargo J, Heron DE, Higgins KA, Beitler JJ, Yao M, Machtay M, Trotti A, Siddiqui F, Lee N
Multi-Institution Analysis of Re-Irradiation for Head and Neck Cancer: Improved Risk-Benefit Profile in the IMRT Era
160 A/B/C
1:40 p.m.
Presenter: Ehsan Balagamwala, MD
Co-Author: Miller JA, Reddy CA, Angelov L, Suh JH, Tariq MB, Yang K, Djemil T, Magnelli A, Mohammadi AM, Soeder S, Chao ST
Recursive partitioning analysis is predictive of overall survival for patients undergoing spine radiosurgery for spine metastasis
206 A/B
2:20 p.m.
Co-Authors: Miller JA, Balagamwala EH, Berriochoa C, Angelov L, Suh JH, Tariq MB, Yang K, Magnelli A, Soeder S, Mohammadi AM, Djemil T, Benzel EC, Chao ST
Advertisement
The Impact of Instrumentation upon Local Control following Spine Stereotactic Radiosurgery
206 A/B
4:05 p.m.
Co-Authors: Miller JA, Kotecha R, Mohammadi AM, Murphy ES, Suh JH, Barnett GH, Vogelbaum MA, Angelov L, Ahluwalia MS, Chao ST
The Economic Implication of Upfront Whole-Brain Radiation Therapy for Patients with Limited Brain Metastasis
206 A/B
4:25 p.m.
Presenter: Bindu Manyam, MD
Co-Authors: Manyam BV, Garsa A, Chin RI, Reddy CA, Gastman B, Vidimos AT, Thorstad W, Yom S, Nussenbaum B, Wang S, Koyfman SA
A Multi-Institutional Comparison of Outcomes of Immunosuppressed and Immunocompetent Patients Treated with Surgery and Radiation Therapy for Cutaneous Squamous Cell Carcinoma of the Head and Neck
104 A/B/C
ePoster
3:15 p.m.
Presenter: Ping Xia, PhD
Authors: Xia P, Yu N, Kolar M, Godley A, Chao S, Tendulkar R, Suh J
Quantitative Measures Improve Safety, Quality, Efficiency in Radiotherapy
Room: 052 A
Advertisement
Advertisement
First-of-its-kind research investigates the viability of standard screening to reduce the burden of late-stage cancer diagnoses
Global R&D efforts expanding first-line and relapse therapy options for patients
Study demonstrates ability to reduce patients’ reliance on phlebotomies to stabilize hematocrit levels
A case study on the value of access to novel therapies through clinical trials
Findings highlight an association between obesity and an increased incidence of moderate-severe disease
Cleveland Clinic Cancer Institute takes multi-faceted approach to increasing clinical trial access 23456
Key learnings from DESTINY trials
Overall survival in patients treated since 2008 is nearly 20% higher than in earlier patients